Aphria Inc. provided revenue guidance for the fiscal year 2020. The company is updating its guidance to primarily reflect certain market dynamics including a slower than expected retail location rollout in Ontario with more than 40 store openings still pending, the temporary banning of vape products in the Province of Alberta while it studies the impact of vape products, the higher costs of third-party supply as a result of the timing of the receipt of Aphria Diamond's license, and a slowing in CC Pharma's growth arising from recent changes in the German government's medical reimbursement model. The company expects net revenue of approximately $575 million to $625 million, with distribution revenue representing slightly more than half of the total net revenue.